Icu Medical [ICUI] vs Avantor [AVTR] Detailed Stock Comparison

Icu Medical

Avantor
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Icu Medical wins in 10 metrics, Avantor wins in 9 metrics, with 0 ties. Icu Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Icu Medical | Avantor | Better |
---|---|---|---|
P/E Ratio (TTM) | -25.27 | 14.15 | Icu Medical |
Price-to-Book Ratio | 1.42 | 1.55 | Icu Medical |
Debt-to-Equity Ratio | 66.40 | 67.49 | Icu Medical |
PEG Ratio | 0.10 | -0.40 | Avantor |
EV/EBITDA | 12.43 | 12.70 | Icu Medical |
Profit Margin (TTM) | -1.56% | 10.31% | Avantor |
Operating Margin (TTM) | 4.88% | 7.63% | Avantor |
EBITDA Margin (TTM) | 4.88% | 7.63% | Avantor |
Return on Equity | -1.78% | 11.73% | Avantor |
Return on Assets (TTM) | 1.84% | 3.24% | Avantor |
Free Cash Flow (TTM) | $113.83M | $692.00M | Avantor |
1-Year Return | -31.88% | -43.54% | Icu Medical |
Price-to-Sales Ratio (TTM) | 1.27 | 1.46 | Icu Medical |
Enterprise Value | $4.12B | $13.54B | Avantor |
EV/Revenue Ratio | 1.74 | 2.03 | Icu Medical |
Gross Profit Margin (TTM) | 37.91% | 32.92% | Icu Medical |
Revenue per Share (TTM) | $97 | $10 | Icu Medical |
Earnings per Share (Diluted) | $-1.52 | $1.01 | Avantor |
Beta (Stock Volatility) | 0.83 | 0.98 | Icu Medical |
Icu Medical vs Avantor Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Icu Medical | -0.57% | 2.74% | -1.64% | -9.87% | -13.77% | -22.73% |
Avantor | -1.40% | 20.69% | 11.47% | 2.95% | -8.81% | -32.59% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Icu Medical | -31.88% | -18.61% | -36.37% | 17.79% | 227.00% | 333.80% |
Avantor | -43.54% | -28.98% | -41.63% | -1.45% | -1.45% | -1.45% |
News Based Sentiment: Icu Medical vs Avantor
Icu Medical
News based Sentiment: MIXED
ICU Medical is presenting a mixed investment story this month. While analysts suggest significant undervaluation and insider buying indicates confidence, the company is grappling with declining sales, high debt, and a recent FDA warning. These conflicting signals create a complex picture for investors.
Avantor
News based Sentiment: MIXED
October was a dynamic month for Avantor, with a surge in stock price due to activist investor activity balanced by mixed analyst ratings and a cautious adjustment of price targets. The upcoming earnings release on October 29th will be crucial in determining the company's trajectory.
Performance & Financial Health Analysis: Icu Medical vs Avantor
Metric | ICUI | AVTR |
---|---|---|
Market Information | ||
Market Cap | $3.06B | $9.74B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 259,010 | 10,132,900 |
90 Day Avg. Volume | 280,250 | 11,070,000 |
Last Close | $121.38 | $14.09 |
52 Week Range | $107.00 - $196.26 | $10.82 - $26.14 |
% from 52W High | -38.15% | -46.10% |
All-Time High | $321.70 (Aug 06, 2018) | $44.37 (Sep 20, 2021) |
% from All-Time High | -62.27% | -68.24% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.08% | -0.01% |
Quarterly Earnings Growth | -0.08% | -0.30% |
Financial Health | ||
Profit Margin (TTM) | -0.02% | 0.10% |
Operating Margin (TTM) | 0.05% | 0.08% |
Return on Equity (TTM) | -0.02% | 0.12% |
Debt to Equity (MRQ) | 66.40 | 67.49 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $85.71 | $9.22 |
Cash per Share (MRQ) | $12.15 | $0.66 |
Operating Cash Flow (TTM) | $138.83M | $681.80M |
Levered Free Cash Flow (TTM) | $247.93M | $688.84M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Icu Medical vs Avantor
Metric | ICUI | AVTR |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -25.27 | 14.15 |
Forward P/E | 17.87 | 12.65 |
PEG Ratio | 0.10 | -0.40 |
Price to Sales (TTM) | 1.27 | 1.46 |
Price to Book (MRQ) | 1.42 | 1.55 |
Market Capitalization | ||
Market Capitalization | $3.06B | $9.74B |
Enterprise Value | $4.12B | $13.54B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.74 | 2.03 |
Enterprise to EBITDA | 12.43 | 12.70 |
Risk & Other Metrics | ||
Beta | 0.83 | 0.98 |
Book Value per Share (MRQ) | $85.71 | $9.22 |
Financial Statements Comparison: Icu Medical vs Avantor
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ICUI | AVTR |
---|---|---|
Revenue/Sales | $604.70M | $1.58B |
Cost of Goods Sold | $394.59M | $1.05B |
Gross Profit | $210.11M | $534.90M |
Research & Development | $23.29M | N/A |
Operating Income (EBIT) | $29.59M | $147.40M |
EBITDA | $82.47M | $230.80M |
Pre-Tax Income | $-10.91M | $85.70M |
Income Tax | $4.57M | $21.20M |
Net Income (Profit) | $-15.48M | $64.50M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ICUI | AVTR |
---|---|---|
Cash & Equivalents | $289.70M | $315.70M |
Total Current Assets | $1.42B | $2.28B |
Total Current Liabilities | $549.02M | $2.03B |
Long-Term Debt | $1.54B | $3.28B |
Total Shareholders Equity | $1.99B | $6.10B |
Retained Earnings | $674.68M | $2.27B |
Property, Plant & Equipment | $466.20M | N/A |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ICUI | AVTR |
---|---|---|
Operating Cash Flow | $90.80M | $86.60M |
Capital Expenditures | $-14.62M | N/A |
Free Cash Flow | $34.47M | $81.30M |
Debt Repayment | $-48.08M | $-31.30M |
Common Stock Repurchase | N/A | $-4.90M |
Short Interest & Institutional Ownership Analysis
Metric | ICUI | AVTR |
---|---|---|
Shares Short | 1.45M | 25.06M |
Short Ratio | 4.64 | 2.26 |
Short % of Float | 0.07% | 0.05% |
Average Daily Volume (10 Day) | 259,010 | 10,132,900 |
Average Daily Volume (90 Day) | 280,250 | 11,070,000 |
Shares Outstanding | 24.52M | 680.80M |
Float Shares | 23.90M | 663.95M |
% Held by Insiders | 0.03% | 0.01% |
% Held by Institutions | 1.13% | 1.06% |
Dividend Analysis & Yield Comparison: Icu Medical vs Avantor
Metric | ICUI | AVTR |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |